Wider patient access to CGTs hinges on further infrastructure developments and the movement of therapies into the community setting.

Covid-19 has created a perfect storm for cybercrime, giving hackers both the means and the motivation to step up their criminal activities. Credit: Getty Images At the start of the Covid-19 pandemic, ...

J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.

AbbVie's Rinvoq, Pfizer and BioNTech's Comirnaty and Incyte's Opzelura have all received their own EU drug regulatory approvals this week.

An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the UK despite the branded medicine’s manufacturer warning of safety concerns.

Recule has signed a research collaboration with Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted RNA therapeutics delivery to tissues beyond ...

Regenerative medicine offers an innovative approach to treating different indications by restoring damaged or diseased cells and tissues.

BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.

Eisai has entered an exclusive global licensing agreement with CORE Biomedicine for several preclinical oncology programmes.

GSK will reallocate a large portion of the £1.9bn saved through to 2029 towards late-stage pipeline acceleration, primarily in oncology.

Data integrity has become a defining compliance risk. Paper-based systems and hybrid environments where data is manually transcribed between disconnected systems simply can’t satisfy that standard ...

Wet AMD is an eye disorder characterised by leaky vessels in the retina causing vision loss. Credit: PeopleImages/Shutterstock.com. Following years of regulatory setbacks that saw multiple rejections, ...